Cramer's Take on Headline Stocks

(Updated with closing stock prices.)

Abbott Labs(ABT Quote) will pay Johnson & Johnson(JNJ Quote) about $1.7 billion according to a the ruling in a patent infringement suit regarding Abbott's Humira and J&J's Centocor, which both treat rheumatoid arthritis.

On Tuesday, Abbott closed down 78 cents, or 1.6%, at $47.04.

RHJ International, a Belgium industrial company, is close to purchasing a stake in General Motors'(GMGMQ Quote) Opel division after revising a previous offer. The Financial Times reports that the deal could be settled in a matter of days.

Apollo Group(APOL Quote) reported third-quarter earnings of $201.1 million, or $1.26 a share, up 45% from the same quarter last year, after an increase in enrollment at its education programs. Revenue also increased, by 26% to $1.05 billion.

On Tuesday, Apollo gained $5.13, or 7.8%, to close at $71.12.

In analyst upgrade-downgrade news, Barclays upgraded FedEx(FDX Quote) to overweight from equalweight with a $71 price target, while Merrill Lynch/Bank of America upgraded Electronic Arts(ERTS Quote) to buy from neutral with a $26 price target.

FedEx closed down a penny at $55.62 on Tuesday, while Electronic Arts added 91 cents to $21.72.

With this in mind, we thought we'd take a look at some of the stocks in the news and see what Jim Cramer's had to say about them lately.

To read more, visit Stockpickr.com.